[ Price : $8.95]
FDA lifts a clinical hold against 4D Molecular Therapeutics 4D-310 therapy being studied for treating Fabry disease cardiomyopathy...[ Price : $8.95]
Federal Register notice: FDA announces an 11/19 advisory committee meeting to discuss potential changes to the clozapine risk eval...[ Price : $8.95]
FDA publishes a draft guidance on developing drug and biological treatments for a specific bladder cancer.[ Price : $8.95]
FDA approves a Citius Pharmaceuticals BLA for Lymphir (denileukin diftitox-cxdl) for treating relapsed or refractory cutaneous T-c...[ Price : $8.95]
FDA approves a Purdue Pharma NDA for Zurnai, a nalmefene hydrochloride auto-injector for the emergency treatment of known or suspe...[ Price : $8.95]
FDA releases the form FDA-483 with four observations from an inspection at the Ledgewood, NJ-based Imprimis NJOF outsourcing facil...[ Price : $8.95]
Four stakeholders give FDA general and specific recommendations on a draft guidance on bioresearch monitoring inspection processes...[ Price : $8.95]
FDA publishes a guidance on optimizing dosage for oncologic drug and biologic therapies.